357263-48-0 Usage
Uses
Used in Pharmaceutical Industry:
7-Chloro-1H-pyrrolo[3,2-b]pyridine is used as an intermediate in the synthesis of pharmaceutical drugs. Its unique structure and reactivity allow for the development of new and effective medications.
Used in Agrochemical Industry:
7-Chloro-1H-pyrrolo[3,2-b]pyridine is used as a building block in the creation of agrochemical products. Its properties contribute to the development of innovative and efficient solutions for agricultural applications.
Used in Organic Chemistry Research:
7-Chloro-1H-pyrrolo[3,2-b]pyridine serves as a substrate in various organic chemistry reactions, enabling researchers to explore new reaction pathways and synthesize novel compounds with potential applications in various fields.
Used in Drug Development:
Due to its unique structure, 7-chloro-1H-pyrrolo[3,2-b]pyridine is utilized in the research and development of new drugs. Its reactivity and potential to form various derivatives make it a valuable component in the drug discovery process.
Check Digit Verification of cas no
The CAS Registry Mumber 357263-48-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,7,2,6 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 357263-48:
(8*3)+(7*5)+(6*7)+(5*2)+(4*6)+(3*3)+(2*4)+(1*8)=160
160 % 10 = 0
So 357263-48-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2/c8-5-1-3-9-6-2-4-10-7(5)6/h1-4,10H
357263-48-0Relevant articles and documents
AKT PROTEIN KINASE INHIBITORS
-
, (2008/06/13)
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.